BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8615154)

  • 1. Autonomic nervous system dysfunction and adrenoceptor regulation in Parkinson's disease. Clinical and pharmacological consequences.
    Montastruc JL; Senard JM; Rascol O; Rascol A
    Adv Neurol; 1996; 69():377-81. PubMed ID: 8615154
    [No Abstract]   [Full Text] [Related]  

  • 2. [Disorders of autonomic regulation in Parkinson syndrome].
    Jost WH
    Fortschr Neurol Psychiatr; 1995 May; 63(5):194-205. PubMed ID: 7782020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of orthostatic hypotension in Parkinson's disease: from pathophysiology to management.
    Pathak A; Senard JM
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):393-403. PubMed ID: 15151485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autonomic dysfunction in Parkinson's disease.
    Dewey RB
    Neurol Clin; 2004 Oct; 22(3 Suppl):S127-39. PubMed ID: 15501361
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigational drugs for autonomic dysfunction in Parkinson's disease.
    Perez-Lloret S
    Expert Opin Investig Drugs; 2016; 25(3):259-62. PubMed ID: 26757448
    [No Abstract]   [Full Text] [Related]  

  • 6. Autonomic disorders in idiopathic parkinsonism.
    Martignoni E; Micieli G; Cavallini A; Pacchetti C; Magri M; Nappi G
    J Neural Transm Suppl; 1986; 22():149-61. PubMed ID: 3465869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs to treat autonomic dysfunction in Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S103-11. PubMed ID: 12211150
    [No Abstract]   [Full Text] [Related]  

  • 8. [Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy].
    Rouco I; Gómez JC; Lezcano E; Aniel-Quiroga MA; Velasco F; Barcena J; Pérez Bas M; Hurtado P; Cruz Lachén M; Zarranz JJ
    Neurologia; 2006 Apr; 21(3):119-23. PubMed ID: 16575624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relation between autonomic dysfunction and progression of Parkinson's disease].
    Oka H; Mochio S; Inoue K
    Rinsho Shinkeigaku; 2001 Jun; 41(6):283-8. PubMed ID: 11771156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug therapy for Parkinson's disease.
    Hermanowicz N
    Semin Neurol; 2007 Apr; 27(2):97-105. PubMed ID: 17390254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of autonomic dysfunction in Parkinson's disease].
    Crespo-Burillo JA; Alarcia-Alejos R
    Rev Neurol; 2015 Apr; 60(8):355-64. PubMed ID: 25857860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of advanced Parkinson's disease.
    Diamond A; Jankovic J
    Expert Rev Neurother; 2006 Aug; 6(8):1181-97. PubMed ID: 16893346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autonomic dysfunction in Parkinson's disease.
    Dubow JS
    Dis Mon; 2007 May; 53(5):265-74. PubMed ID: 17656188
    [No Abstract]   [Full Text] [Related]  

  • 14. Bilateral stimulation of nucleus subthalamicus in advanced Parkinson's disease: no effects on, and of, autonomic dysfunction.
    Holmberg B; Corneliusson O; Elam M
    Mov Disord; 2005 Aug; 20(8):976-81. PubMed ID: 15858814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of early Parkinson's disease. Part 2.
    Simuni T; Lyons KE; Pahwa R; Hauser RA; Comella C; Elmer L; Weintraub D
    Eur Neurol; 2009; 61(4):206-15. PubMed ID: 19176961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing therapeutic effects in patients with comorbidities: drug-resistant tremor, autonomic dysfunction, psychiatric disorders, and cognitive impairment.
    Chitnis S
    Neurol Clin; 2008 Aug; 26(3 Suppl):S29-44, v-vi. PubMed ID: 18774441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenesis and basis of the therapy of Parkinson's disease].
    van der Drift JH; Stoof JC
    Ned Tijdschr Geneeskd; 1981 Apr; 125(16):620-5. PubMed ID: 6113554
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient-reported autonomic symptoms in Parkinson disease.
    Verbaan D; Marinus J; Visser M; van Rooden SM; Stiggelbout AM; van Hilten JJ
    Neurology; 2007 Jul; 69(4):333-41. PubMed ID: 17646625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The patient with Parkinson's disease: part I-treating the motor symptoms; part II-treating the nonmotor symptoms.
    Snyder CH; Adler CH
    J Am Acad Nurse Pract; 2007 Apr; 19(4):179-97. PubMed ID: 17430539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Parkinson's disease a review of current and new therapies.
    Mendis T; Suchowersky O; Lang A; Gauthier S
    Can J Neurol Sci; 1999 May; 26(2):89-103. PubMed ID: 10352867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.